FDA Inspection 1149072 — Alfred A. Lardizabal, MD
The FDA completed an inspection of Alfred A. Lardizabal, MD on July 13, 2021 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Newark, NJ (United States)
Additional Details
Sponsor-Investigator (S-I)